NEW YORK, July 10 - Agilent said today it will license a host of microarray and gene-expression tools to nascent drug-developer Incyte Genomics.
NEW YORK, July 10 - Agilent said today it will license a host of microarray and gene-expression tools to nascent drug-developer Incyte Genomics.